Komori
Techno Medica (6678) · InitiativeRestatedLatest Earnings presentation (2026-05-26): "Advanced"

Revision of Consumables Prices in Response to Soaring Raw Material and Component Prices

First written in FY2024. 4 of 6 entries say "Restated". Latest entry: 2026-05-26.

6entries
3years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2024 – 2026-05-112024: 220242025: 220252026: 22026
Same theme, other companies
Selling Price Revisions Due to Raw Material and Supplier Price IncreasesA theme 121 companies write about · 22 as a headwind · 101 as a tailwind

The whole theme swung hardest in 2020: 2 of 17 companies on the "Worse" side.

69 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 121 companies compared. The sentences above are computed from all 121.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「Despite the impact of soaring raw material costs, we have continued working to ensure a stable supply of consumables and other products.」

    The company continues to ensure a stable supply of consumables and other products amid the ongoing impact of soaring raw material costs. The interim period contains no new disclosure of progress on consumables price revisions.
  2. FY2025RestatedAnnual report

    「Although sales have increased at an annual rate of 4–5% to date, raw material and component prices are rising. We will continue revising consumables prices while providing safe and reliable consumables.」

    In response to soaring raw material and component prices, the company continues to revise consumables prices and ensure a stable supply of safe and reliable consumables.
  3. FY2025-H1RestatedAnnual report

    「For specimen testing equipment, we have sought to expand sales of various products, including handheld and desktop models, in line with customer needs. For consumables and other products, we have continued working to ensure stable supply despite the ongoing impact of soaring raw material costs.」

    The company continues to ensure a stable supply of consumables and other products amid the ongoing impact of soaring raw material costs. Unlike in the previous fiscal year, the interim period contains no new disclosure of progress on consumables price revisions.
  4. FY2024First statedAnnual report

    「Although sales have increased at an annual rate of 4–5% to date, raw material and component prices are rising. We will continue revising consumables prices while providing safe and reliable consumables.」

    While sales of consumables and other products have increased at an annual rate of 4–5%, the company has, for the first time, presented price revisions for consumables as a standalone initiative in response to rising raw material and component prices.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Techno Medica yet. It last moved in the Earnings presentation of 2026-05-26: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Revision of Consumables Prices in Response to Soaring Raw Material and Component Prices | Techno Medica Co.,Ltd. (6678) | Komori